Susan Marie – PESI – Psychopharmacology Conference

Sale!

$44.00

MAIL DELIVERY !!!

Please check your email ( spam, junk box) after your order

Link will be sent to you in an hour 

Description

Description

Psychopharmacology Conference download , Susan Marie – PESI – Psychopharmacology Conference review, Susan Marie – PESI – Psychopharmacology Conference free

Susan Marie – PESI – Psychopharmacology Conference

  • Learn current understanding of how & why mental health medications work
  • Increase your effectiveness communicating and collaborating with prescribing practitioners
  • Understand which medications are evidenced-based to best treat which disorders
  • Improve your clients’ responses and clinical outcomes to medications
  • Help your clients recognize side effects and what their options are with these problems
  • Learn about new trends in prescribing, including changes from DSM-5®
  • Understand current controversies in the field

Spend twelve action-packed hours learning about the newest advances in psychopharmacology and contemporary trends in medication management. From her unique perspective as a doctored psychiatric nurse practitioner, Susan Marie teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Susan’s extensive 30 years of experience in mental health and passion for clients, shines through in the detail and thoroughness of her presentation.

Clients often only have a few minutes with their prescriber and require additional support. It’s vital that you are able to answer their questions, help manage side effects and understand reactions. Designed for counselors, nurses, psychotherapists, psychologists, and other mental health professionals, Susan provides the information you need in order to best help your clients.

This conference allows time for exploration of underrepresented areas, including ADHD, sleep, eating, and substance use disorders. Take home specialized guidelines for geriatrics, pregnant or nursing women, and clients with chronic pain. Discuss how the DSM-5® has impacted prescribing patterns and the use of psychotropics in newly defined diagnoses. In addition to a general ‘nuts and bolts’ review of medications, you will examine case examples, discuss medication controversies and how to effectively collaborate with prescribing practitioners.

Susan’s engaging presentation includes many take home “pearls” you can use to teach your clients about their medications and how to protect them from concerning, dangerous or adverse effects. You will find this conference to have the most up to date medication information and how to use it most effectively with your client.

Speaker

Susan Marie, PhD, PMHNP, CARN-AP
Clinical Associate Professor

Susan Marie, PhD, PMHNP, CARN-AP, a licensed psychiatric nurse practitioner with full independent prescriptive practice and certification in addictions, brings to you over 30 years of clinical experience with highly vulnerable clients with suicidality, co-occurring addiction, homelessness, serious mental illnesses, traumatic brain injuries, and persistent pain conditions. She is noted for her “pearls and pitfalls” of psychopharmacology.  Her passions are radical respect for people with serious mental illnesses & addictions, excellence in psychopharmacology, and integrating psychotherapeutic interventions for clients with PTSD, addictions and chronic pain.

Dr. Marie is Senior Clinical Director for Behavioral Health at Old Town Clinic, Central City Concern and Associate Professor at Oregon Health and Science University in Portland, Oregon.  She teaches nationally on psychopharmacology as well as suicide assessment and intervention.

Speaker Disclosures:

Financial: Susan Marie is an Associate Professor for Oregon Health & Science University. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Susan Marie has no relevant non-financial relationship to disclose.

Target Audience

Counselors, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Psychotherapists, Psychologists, Social Workers, Case Managers, Marriage and Family Therapists, Addiction Counselors, Pharmacists, School Psychologists, Others in caring professions

Outline

  • Psychopharmacology
  • Drug metabolism concepts
  • Drug mechanisms of action- what we know, what we don’t know
  • Placebo effects- power & how to get it to work for your client
  • When to refer for medication- pearls for increasing client interest and participation
  • Developing highly effective collaborations with prescribers
  • Depressive Disorders
  • Neurochemistry of depression
  • Controversy regarding antidepressants and placebo- Who to treat when?
  • Types of antidepressants- pearls and pitfalls of different agents
  • Managing side effects
  • Treatment Resistant depression and drug combinations
  • Anxiety Disorders & Obsessive Compulsive Disorders & Trauma Related Disorders
  • Neurochemistry of anxiety
  • SGAD, panic disorder, phobias
  • OCD
  • PTSD
  • Physiological interventions
  • Anti-anxiety medications
  • Antidepressants
  • The many other options often ignored
  • Benzodiazepines: risks and benefits
  • How to recognize problematic prescribing patterns
  • Getting off benzos: key pearls for success
  • Managing side effects
  • Bipolar Disorders
  • Neurochemistry and symptoms
  • The Bipolar Spectrum concept & DSM-5® changes
  • Types of mood stabilizers, when to use which and potential adverse effects
  • Lithium
  • Anticonvulsants
  • Atypical antipsychotics
  • Augmenting agents
  • Effective strategies for improving outcomes for clients
  • Using blood levels effectively- what the prescriber may not be watching
  • Treating pregnant or potentially pregnant women with bipolar disorder
  • Psychotic Disorders/ Schizophrenia
  • Neurochemistry of psychosis and schizophrenia
  • Antipsychotic Medications:
  • First generation (typical)
  • Second generation (atypical)
  • Managing side effects
  • Extrapyramidal symptoms and TD
  • Metabolic problems- what blood tests are needed and when
  • Preventing Diabetes Mellitus
  • Recognizing hyperprolactinemia- and why you need to know
  • Use of atypical antipsychotics for multiple disorders
  • Pregnancy and psychotic disorders
  • Attentional Disorders
  • Differential diagnosis
  • Neurochemistry of ADHD
  • Controversy about treatment of ADHD with stimulants
  • Substance abuse and ADHD
  • Stimulant medications
  • Non-stimulant options
  • Managing side effects
  • Sleep Disorders
  • Sleep disorders
  • Differential diagnosis
  • Chicken or the egg? What came first, sleep problems or mental illness
  • Controversy about treating sleep problems with hypnotics
  • Sleep interventions that really work
  • Hypnotic medications: risks and benefits
  • Alternatives to hypnotics
  • Recognizing adverse Effects
  • Substance Use Disorders
  • Neurochemistry of addiction & habit development
  • Drugs of abuse and interaction with psychiatric medications
  • Caffeine
  • Nicotine
  • Marijuana (discussion of medical marijuana, cost vs. benefit)
  • Others
  • Challenging the old thinking about when to prescribe for clients with dual diagnosis-what we now know
  • Medication assisted treatments for addictions
  • Alcohol
  • Nicotine
  • Cannabis
  • Opiates
  • Behavioral addictions- what we know works
  • Eating Disorders
  • Anorexia, bulimia, binge eating disorder
  • Weight gain from psychotropic medications
  • Recognizing medical emergencies
  • Standard of care for lab work
  • Integrating psychotherapy with psychopharmacology
  • Special Populations: Geriatric
  • Specialized guidelines for geriatric clients
  • Discussion of dementia treatment
  • Antipsychotic controversy
  • Special Populations: Women
  • Hormonal issues in mood disorders & anxiety
  • Pregnancy and breastfeeding-
  • Presenting the choices
  • Resources for you and your clients
  • The dangerous, the concerning, and the possibly good options for psychopharmacology
  • Menopause- current knowledge and agents
  • Treating Clients with Comorbid Chronic Pain
  • Neurochemistry implications- why it’s critical to intervene
  • When psychopharmacology can help
  • Other alternative interventions
  • Limitations of The Research & Potential Risks

Objectives

Day 1:

  • Specify how psychotropic medications are chosen for mood disorders and specific patient characteristics.
  • Analyze the actions, therapeutic uses, and side effects of antidepressants.
  • Assist clients in overcoming barriers that impede the efficacy of their medication regime.
  • Determine options for clients with treatment resistant mood disorders.
  • Communicate the actions, side effects, and therapeutic uses of antipsychotic medications.
  • Evaluate three critical strategies for improving collaboration with prescribing practitioners.

Day 2:

  • Explore psychotropic medication treatment options for clients with Attention Deficit/Hyperactivity Disorder.
  • Articulate the efficacy of psychotropic medications in treating eating disorders and discuss how to integrate psychotherapy with psychopharmacology for successful treatment outcomes.
  • Formulate medication treatment options for substance use disorders and discuss how to effectively incorporate medication assisted treatments into an overall plan for care.
  • Analyze the interaction between women’s hormone levels and their mental health symptoms.
  • Explore the use of complementary and alternative agents for treatment of mental illnesses.
  • Determine the unique medication treatment considerations for geriatric clients.Commonly Asked Questions:
    1. Business Model Innovation: Acknowledge the reality of a legitimate enterprise! Our approach involves the coordination of a collective purchase, in which the costs are shared among the participants. We utilize this cash to acquire renowned courses from sale pages and make them accessible to individuals with restricted financial resources. Our clients appreciate the affordability and accessibility we provide, despite the authors’ concerns.
    2. Psychopharmacology Conference Course
    • There are no scheduled coaching calls or sessions with the author.
    • Access to the author’s private Facebook group or web portal is not permitted.
    • No access to the author’s private membership forum.
    • There is no direct email support available from the author or their team.
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Susan Marie – PESI – Psychopharmacology Conference”

Your email address will not be published.